Added to YB: 2024-09-11
Pitch date: 2024-09-10
CLPT [bearish]
ClearPoint Neuro, Inc.
+22.42%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$12.09
Price Target
6.00 (-36%)
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
value
$CLPT Short idea -- PT ~6/sh downside 50%
CLPT short: Overvalued at 10x P/S vs. 5x fair value. Weak fundamentals: 23% rev CAGR, declining margins, negative EBITDA/EPS/CFO, share dilution. Hype-driven 120% surge on partner data & earnings, but no real catalysts. OR & LITT products face tough competition. $6 PT.
Read full article (3 min)